Prudential Financial’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Prudential Financial’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-122,300	Closed	-$1.64M	–	2513
2019 Q1	$1.64M	Sell	122,300 -110,721	-48%	-$1.26M	﹤0.01%	1684
2018 Q4	$2.17M	Buy	233,021 +66,231	+40%	+$788K	﹤0.01%	1479
2018 Q3	$2.32M	Buy	166,790 +24,760	+17%	+$368K	﹤0.01%	1561
2018 Q2	$2.25M	Buy	+142,030	New	+$2.48M	﹤0.01%	1589
2017 Q2	–	Sell	-31,430	Closed	-$1.14M	–	2391
2017 Q1	$1.14M	Sell	31,430 -33,356	-51%	-$1.47M	﹤0.01%	1817
2016 Q4	$3.25M	Buy	64,786 +15,800	+32%	+$830K	0.01%	1303
2016 Q3	$2.57M	Buy	48,986 +28,494	+139%	+$1.36M	﹤0.01%	1383
2016 Q2	$848K	Buy	+20,492	New	+$891K	﹤0.01%	1879
2015 Q4	–	Sell	-42,000	Closed	-$646K	–	2286
2015 Q3	$646K	Sell	42,000 -9,900	-19%	-$213K	﹤0.01%	1892
2015 Q2	$1.29M	Sell	51,900 -51,800	-50%	-$1.15M	﹤0.01%	1736
2015 Q1	$2.37M	Buy	103,700 +60,000	+137%	+$1.51M	﹤0.01%	1516
2014 Q4	$1.18M	Buy	+43,700	New	+$752K	﹤0.01%	1687

Other funds holding FPRX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prudential Financial's FPRX Position: Q2 2019 in Review

Prudential Financial sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2019, closing a stake of 122,300 shares — an estimated $1.64M sold.

Prudential Financial first reported a position in FPRX in Q4 2014 and held it in 12 quarters. The position peaked at $3.25M in Q4 2016. 114 funds tracked by Wall St. Rank hold FPRX as of Q2 2019.

Prudential Financial reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
Prudential Financial sold 122,300 Five Prime Therapeutics, Inc. shares in Q2 2019, an estimated $1.64M.
Prudential Financial first reported a position in Five Prime Therapeutics, Inc. in Q4 2014 and held it in 12 quarters.
Prudential Financial's Five Prime Therapeutics, Inc. position peaked at $3.25M in Q4 2016.
114 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2019.

Based on Prudential Financial's 13F filing for Q2 2019, filed 8 Aug 2019.